A new-generation stable inducible packaging cell line for lentiviral vectors

Human Gene Therapy

Volumn 12, Issue 8, 2001, Pages 981-997

  Farson, D ^a   Witt, R ^a   McGuinness, R ^a   Dull, T ^a   Kelly, M ^a   Song, J ^a   Radeke, R ^a   Bukovsky, A ^a   Consiglio, A ^b   Naldini, L ^c  

^a CELL GENESYS INC   (United States)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ETOPOSIDE; GAG PROTEIN; REV PROTEIN; TETRACYCLINE; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; VESICULAR STOMATITIS VIRUS PROTEIN G; VIRUS ENVELOPE PROTEIN; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL LINE; CLONE; CONTROLLED STUDY; DNA PACKAGING; GENE CONSTRUCT; GENE EXPRESSION; GENE INDUCTION; GENE REPLICATION; GENE SEQUENCE; GENE TARGETING; GENE TRANSFER; GENETIC CODE; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; LENTIVIRINAE; MOUSE; NONHUMAN; PROMOTER REGION; REPRESSOR GENE; TRANSGENE; VESICULAR STOMATITIS VIRUS;

ANIMALS; ANTI-BACTERIAL AGENTS; BLOTTING, SOUTHERN; BRAIN; CELL DIVISION; CELL LINE; FUSION PROTEINS, GAG-POL; GENE PRODUCTS, REV; GENE PRODUCTS, TAT; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HELA CELLS; HIV-1; HUMANS; LENTIVIRUS; LUMINESCENT PROTEINS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MODELS, GENETIC; PLASMIDS; RECOMBINANT FUSION PROTEINS; RECOMBINATION, GENETIC; TETRACYCLINE; TIME FACTORS; TRANSDUCTION, GENETIC; TRANSFECTION; TRANSGENES; VIRAL ENVELOPE PROTEINS;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS; VESICULAR STOMATITIS VIRUS;

EID: 0034914353     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303401750195935     Document Type: Article

References (46)

1. Replication and pathogenicity of human immunodeficiency virus type 1 accessory gene mutants in SCID-hu mice
2. Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage checkpoint control
3. Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription
4. Interaction of human immunodeficiency virus-derived vectors with wild-type virus in transduced cells
5. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: Concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells
6. A human immunodeficiency virus type 1 (HIV-1)-based retroviral vector system utilizing stable HIV-1 packaging cell lines
7. HIV-1 auxiliary proteins: Making connections in a dying cell
8. Retroviral particles produced from a stable human-derived packaging cell line transduce target cells with very high efficiencies
9. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients
10. A third-generation lentivirus vector with a conditional packaging system
11. Kat: A high-efficiency retroviral transduction system for primary human T lymphocytes
12. CRM1 is an export receptor for leucine-rich nuclear export signals
13. HIV nuclear import is governed by the phosphotyrosine- mediated binding of matrix to the core domain of integrase
14. Requirements for efficient production and transduction of human immunodeficiency virus type 1-based vectors
15. Transcriptional activation by tetracyclines in mammalian cells
16. Self-inactivating lentiviral vectors with U3 and U5 modifications
17. A packaging cell line for lentivirus vectors
18. Regulated lentiviral packaging cell line devoid of most viral cis-acting sequences
19. Minimal requirement for a lentivirus vector based on human immunodeficiency virus type 1
20. Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: Evidence for differential gene expression
21. Episomal vectors rapidly and stably produce high-titer recombinant retrovirus
22. Brief report: Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection
23. An active-site mutation in the human immunodeficiency virus type 1 proteinase (PR) causes reduced PR activity loss of PR-mediated cytotoxicity without apparent effect on virus maturation infectivity
24. Recognition of AUG and alternative initiator codons is augmented by G in position +4 but is not generally affected by the nucleotides in positions +5 and +6
25. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein
26. The human immunodeficiency virus type 1 encapsidation site is a multipartite RNA element composed of functional hairpin structures
27. Efficient encapsidation of human immunodeficiency virus type 1 vectors and further characterization of cis elements required for encapsidation
28. The cytotoxicity of human immunodeficiency virus type 1 Rev: Implications for its interaction with the nucleolar protein B23
29. Development of a self-inactivating lentivirus vector
30. High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells
31. Lentiviruses as gene transfer agents for delivery to nondividing cells
32. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector
33. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector
34. The importin-beta family member Crm1p bridges the interaction between Rev and the nuclear pore complex during nuclear export
35. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes
36. Production of high-titer helper-free retroviruses by transient transfection
37. Inactivation of the human immunodeficiency virus type 1 inhibitory elements allows Rev-independent expression of Gag and Gag/protease and particle formation
38. The effect of viral regulatory protein expression on gene delivery by human immunodeficiency virus type 1 vectors produced in stable packaging cell lines
39. Exportin 1 (Crm1p) is an essential nuclear export factor
40. The tat/rev intron of human immunodeficiency virus type 1 is inefficiently spliced because of suboptimal signals in the 3′ splice site
41. Development of high-titer retroviral producer cell lines by using Cre-mediated recombination
42. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA
43. Generation of retroviral vector for clinical studies using transient transfection
44. Inducible human immunodeficiency virus type 1 packaging cell lines
45. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
46. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery